Christine Swenson

Christine Swenson Senior Vice President of Regulatory Affairs

Christine Swenson is the Senior Vice President of Regulatory Affairs. She has more than 30 years of drug development experience, including extensive leadership of domestic and international regulatory affairs spanning early- and clinical-stage development of both biologics and small molecules across multiple therapeutic areas. Before joining Beam, Ms. Swenson was the senior vice president, global regulatory affairs at Moderna, where she led the development and execution of regulatory strategies for its portfolio of mRNA therapeutics and vaccines. Prior to Moderna, she held leadership roles in regulatory affairs, which included global regulatory lead for the Yervoy and Opdivo immuno-oncology programs at Bristol-Myers Squibb, Adnexus, ImmunoGen and Coley Pharmaceutical Group.

Ms. Swenson received a B.S. in biology from Stonehill College.